Patients Engaging change: Connecting patients and regulators can move... Face-to-face discussion educates regulators on what matters most to patients, and guides future decision-making.
Oncology On nuclear medicine and oncology, SHINE technologies Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
